NGGT Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $40M

  • Investors
  • 10

NGGT General Information

Description

Developer of gene therapy treatments designed for the treatment of rare genetic diseases. The company's technology utilizes a dual-function vector that expresses a silencing agent to reduce toxic mutants while introducing a genetically engineered copy of the targeted gene, providing the healthcare sector with treatments for metabolic and retinal diseases to address the underlying genetic cause of rare conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 101, Building 5, Phase III, Biomedical Industrial Park
  • Number 1 Xinze Road, Suzhou Industrial Park, Suzhou Area of China Pilot Free Trade Zone
  • Suzhou, Jiangsu 210000
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Unit 101, Building 5, Phase III, Biomedical Industrial Park
  • Number 1 Xinze Road, Suzhou Industrial Park, Suzhou Area of China Pilot Free Trade Zone
  • Suzhou, Jiangsu 210000
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NGGT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 11-Jul-2023 $40M Completed Generating Revenue
2. Early Stage VC (Series A) 15-Apr-2021 Completed Generating Revenue
1. Seed Round Completed Startup
To view NGGT’s complete valuation and funding history, request access »

NGGT Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Guangda Huitong Private Equity Fund Management Growth/Expansion Minority
Detong Capital Venture Capital Minority
Infinity Group PE/Buyout Minority
Leader Venture Capital Growth/Expansion Minority
Shanghai Healthcare Capital PE/Buyout Minority
You’re viewing 5 of 10 investors. Get the full list »

NGGT FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process